After a Ph.D and postdoctoral positions in the UK and USA in protein biochemistry Peter joined Celltech (now part of UCB Pharma). There he was involved in biologics discovery. His next relevant position was with Roche where he became a senior manager in Biological Technology discovering small molecule antiviral drugs against HIV, Flu and Hepatitis C. Peter then went on to leadership positions in small/mid-sized Biotech companies in the UK and Switzerland before starting a Pharma-Biotech consultancy based near Cambridge, UK.
This drug discovery training course takes you on a science-based drug discovery journey. You will travel from inception of a new project to the point of hand-over of the newly discovered molecule to the Drug Development Team for pre-clinical and clinical studies. The course breaks down the long, multi-faceted drug discovery process into individual steps which build towards this key goal. The focus is on how essential science, technology and infrastructure elements are constituted, deployed and integrated to maximise the likelihood of a successful drug discovery project.